| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.08e-04 | 599 | 44 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 5.58e-04 | 16 | 44 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 5.58e-04 | 16 | 44 | 2 | GO:0031404 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.33e-05 | 3 | 44 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 2.66e-05 | 4 | 44 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | courtship behavior | 9.28e-05 | 7 | 44 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | brainstem development | 1.24e-04 | 8 | 44 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.98e-04 | 10 | 44 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.42e-04 | 11 | 44 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 3.42e-04 | 13 | 44 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.42e-04 | 13 | 44 | 2 | GO:0097090 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.83e-05 | 4 | 46 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.64e-04 | 13 | 46 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.91e-04 | 157 | 46 | 4 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic density | 4.40e-04 | 451 | 46 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.91e-04 | 477 | 46 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.80e-04 | 503 | 46 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | glycinergic synapse | 8.78e-04 | 20 | 46 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 9.55e-04 | 523 | 46 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 9.87e-04 | 201 | 46 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.27e-03 | 24 | 46 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | postsynapse | 1.54e-03 | 1018 | 46 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.69e-03 | 107 | 46 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | desmosome | 1.73e-03 | 28 | 46 | 2 | GO:0030057 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.90e-03 | 405 | 46 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.92e-03 | 817 | 46 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.12e-03 | 31 | 46 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.29e-03 | 253 | 46 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | axon | 3.13e-03 | 891 | 46 | 7 | GO:0030424 | |
| Domain | NLGN4 | 5.42e-06 | 2 | 44 | 2 | IPR030025 | |
| Domain | Tox-GHH_dom | 3.24e-05 | 4 | 44 | 2 | IPR028916 | |
| Domain | Ten_N | 3.24e-05 | 4 | 44 | 2 | IPR009471 | |
| Domain | Ten_N | 3.24e-05 | 4 | 44 | 2 | PF06484 | |
| Domain | TENEURIN_N | 3.24e-05 | 4 | 44 | 2 | PS51361 | |
| Domain | Tox-GHH | 3.24e-05 | 4 | 44 | 2 | PF15636 | |
| Domain | Nlgn | 5.40e-05 | 5 | 44 | 2 | IPR000460 | |
| Domain | YD | 5.40e-05 | 5 | 44 | 2 | IPR006530 | |
| Domain | CRAL_TRIO_N | 2.94e-04 | 11 | 44 | 2 | PF03765 | |
| Domain | CRAL-bd_toc_tran | 3.53e-04 | 12 | 44 | 2 | IPR001071 | |
| Domain | CRAL_TRIO_N | 3.53e-04 | 12 | 44 | 2 | SM01100 | |
| Domain | NHL | 4.16e-04 | 13 | 44 | 2 | PS51125 | |
| Domain | Carboxylesterase_B_CS | 4.16e-04 | 13 | 44 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.85e-04 | 14 | 44 | 2 | PS00941 | |
| Domain | COesterase | 4.85e-04 | 14 | 44 | 2 | PF00135 | |
| Domain | CarbesteraseB | 4.85e-04 | 14 | 44 | 2 | IPR002018 | |
| Domain | CRAL/TRIO_N_dom | 5.59e-04 | 15 | 44 | 2 | IPR011074 | |
| Domain | - | 9.66e-04 | 679 | 44 | 7 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.09e-03 | 693 | 44 | 7 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.10e-03 | 694 | 44 | 7 | IPR013087 | |
| Domain | CRAL_TRIO | 1.11e-03 | 21 | 44 | 2 | PF00650 | |
| Domain | - | 1.33e-03 | 23 | 44 | 2 | 3.40.525.10 | |
| Domain | SEC14 | 1.57e-03 | 25 | 44 | 2 | SM00516 | |
| Domain | CRAL_TRIO | 1.83e-03 | 27 | 44 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 1.97e-03 | 28 | 44 | 2 | IPR001251 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.07e-03 | 775 | 44 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.10e-03 | 777 | 44 | 7 | PS00028 | |
| Domain | Znf_C2H2-like | 2.40e-03 | 796 | 44 | 7 | IPR015880 | |
| Domain | Arm | 2.42e-03 | 31 | 44 | 2 | PF00514 | |
| Domain | Znf_C2H2 | 2.56e-03 | 805 | 44 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.62e-03 | 808 | 44 | 7 | SM00355 | |
| Domain | - | 3.80e-03 | 39 | 44 | 2 | 2.120.10.30 | |
| Domain | ARM_REPEAT | 4.00e-03 | 40 | 44 | 2 | PS50176 | |
| Domain | ARM | 4.00e-03 | 40 | 44 | 2 | SM00185 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.26e-03 | 46 | 44 | 2 | IPR011042 | |
| Domain | Armadillo | 5.48e-03 | 47 | 44 | 2 | IPR000225 | |
| Domain | zf-C2H2_6 | 6.27e-03 | 314 | 44 | 4 | PF13912 | |
| Domain | KRAB | 9.86e-03 | 358 | 44 | 4 | PS50805 | |
| Domain | KRAB | 9.86e-03 | 358 | 44 | 4 | PF01352 | |
| Domain | KRAB | 1.09e-02 | 369 | 44 | 4 | SM00349 | |
| Domain | KRAB | 1.10e-02 | 370 | 44 | 4 | IPR001909 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29106499 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 1.71e-06 | 2 | 46 | 2 | 24104404 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 38972355 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 1.71e-06 | 2 | 46 | 2 | 32243781 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22989184 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18434543 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19651769 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29533464 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 23183221 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 1.71e-06 | 2 | 46 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 1.71e-06 | 2 | 46 | 2 | 37080762 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.88e-06 | 281 | 46 | 6 | 28706196 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18628683 | ||
| Pubmed | Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1. | 5.13e-06 | 3 | 46 | 2 | 19234190 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 32011705 | ||
| Pubmed | Inflammasome-independent role of NLRP12 in suppressing colonic inflammation regulated by Blimp-1. | 5.13e-06 | 3 | 46 | 2 | 27105524 | |
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 5.13e-06 | 3 | 46 | 2 | 21282647 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.03e-05 | 4 | 46 | 2 | 10225957 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 16077734 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 17292328 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.03e-05 | 4 | 46 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.03e-05 | 4 | 46 | 2 | 22671294 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 20579107 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.03e-05 | 4 | 46 | 2 | 12000766 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 25164809 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.71e-05 | 5 | 46 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.71e-05 | 5 | 46 | 2 | 10996085 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 37865312 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 21838267 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 29724786 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 12915301 | ||
| Pubmed | 4.31e-05 | 51 | 46 | 3 | 16919471 | ||
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 10331952 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 4.77e-05 | 8 | 46 | 2 | 30871858 | |
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 23010509 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 34584102 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 6.12e-05 | 9 | 46 | 2 | 29252214 | |
| Pubmed | 6.51e-05 | 163 | 46 | 4 | 16512683 | ||
| Pubmed | 7.65e-05 | 10 | 46 | 2 | 38713721 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 32973045 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 26403076 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 9.78e-05 | 67 | 46 | 3 | 34644545 | |
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 32277911 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 1.32e-04 | 13 | 46 | 2 | 27050589 | |
| Pubmed | Cdc42 activation by endothelin regulates neural crest cell migration in the cardiac outflow tract. | 1.32e-04 | 13 | 46 | 2 | 31219639 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 18227507 | ||
| Pubmed | 2.42e-04 | 91 | 46 | 3 | 22610502 | ||
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 5.04e-04 | 25 | 46 | 2 | 30309841 | |
| Pubmed | 5.07e-04 | 117 | 46 | 3 | 22174793 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 5.45e-04 | 26 | 46 | 2 | 34848499 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.46e-04 | 120 | 46 | 3 | 31413325 | |
| Pubmed | Requirements for Neurogenin2 during mouse postnatal retinal neurogenesis. | 6.79e-04 | 29 | 46 | 2 | 30048641 | |
| Pubmed | Role of Elavl-like RNA-binding protein in retinal development and signal transduction. | 7.77e-04 | 31 | 46 | 2 | 39307290 | |
| Pubmed | 7.77e-04 | 31 | 46 | 2 | 23469192 | ||
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 8.89e-04 | 142 | 46 | 3 | 11812828 | |
| Pubmed | 9.35e-04 | 34 | 46 | 2 | 20007774 | ||
| Pubmed | 9.83e-04 | 147 | 46 | 3 | 16959763 | ||
| Pubmed | 1.06e-03 | 151 | 46 | 3 | 17043677 | ||
| Pubmed | 1.23e-03 | 39 | 46 | 2 | 22802532 | ||
| Pubmed | Protein-protein interaction panel using mouse full-length cDNAs. | 1.28e-03 | 161 | 46 | 3 | 11591653 | |
| Cytoband | 6q22.31 | 3.39e-04 | 27 | 46 | 2 | 6q22.31 | |
| Cytoband | 1p36.22 | 6.40e-04 | 37 | 46 | 2 | 1p36.22 | |
| Cytoband | 9q32 | 1.03e-03 | 47 | 46 | 2 | 9q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q32 | 1.17e-03 | 50 | 46 | 2 | chr9q32 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.46e-03 | 43 | 31 | 2 | 409 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.02e-03 | 718 | 31 | 5 | 28 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-08 | 184 | 46 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-06 | 184 | 46 | 5 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-06 | 194 | 46 | 5 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-06 | 194 | 46 | 5 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 196 | 46 | 5 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 196 | 46 | 5 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 196 | 46 | 5 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.11e-05 | 174 | 46 | 4 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 175 | 46 | 4 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.32e-05 | 177 | 46 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 46 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.20e-05 | 188 | 46 | 4 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-05 | 197 | 46 | 4 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-05 | 197 | 46 | 4 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.24e-05 | 199 | 46 | 4 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 46 | 4 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.39e-06 | 197 | 45 | 6 | 1324_UP | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | 2.61e-06 | 200 | 45 | 6 | 2167_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.95e-05 | 194 | 45 | 5 | 2742_DN | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 6824_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 2451_UP | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 6305_UP | |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 6364_UP | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 5072_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; HL60; HT_HG-U133A | 4.46e-05 | 199 | 45 | 5 | 2399_UP | |
| Disease | Drug habituation | 6.80e-04 | 115 | 44 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 6.80e-04 | 115 | 44 | 3 | C0236969 | |
| Disease | Drug abuse | 6.80e-04 | 115 | 44 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 6.80e-04 | 115 | 44 | 3 | C0013222 | |
| Disease | Drug Dependence | 6.80e-04 | 115 | 44 | 3 | C1510472 | |
| Disease | Substance Dependence | 6.80e-04 | 115 | 44 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 6.80e-04 | 115 | 44 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 6.80e-04 | 115 | 44 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 6.80e-04 | 115 | 44 | 3 | C4316881 | |
| Disease | Substance abuse problem | 6.97e-04 | 116 | 44 | 3 | C0740858 | |
| Disease | response to vaccine, cytokine measurement | 9.91e-04 | 131 | 44 | 3 | EFO_0004645, EFO_0004873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYRVQECNYNRLQHA | 486 | Q99569 | |
| QMREAYCLQYSNNLQ | 126 | Q9UJ72 | |
| ACQVYFINQDMQLYD | 386 | O60312 | |
| TNQNLQYFLDRFYMN | 151 | Q16654 | |
| NQDYLDICTYQRLQQ | 276 | Q7Z5J8 | |
| QVNVLLYDMNGCYSR | 61 | P41134 | |
| QRYYENGMTNQSKNC | 16 | Q7Z353 | |
| QNQIRNCYQNFLDYH | 26 | Q6YFQ2 | |
| SYNRACELAQMVQLY | 571 | Q86SJ6 | |
| FQNRDYQCDTVMLLN | 1196 | O94915 | |
| LQQYQEVCAQRDAYQ | 821 | Q5T1M5 | |
| MDEQRRQNVAYQYLC | 21 | Q86VI3 | |
| MTYVQDQNEDCLYLN | 136 | Q8NFZ3 | |
| FRNHTACMEEQYNQY | 751 | P0DPD8 | |
| AYDNVYQQLQHCLLM | 191 | Q8NA47 | |
| DAYYEQQMAARQANA | 486 | Q6UUV9 | |
| FRINEANQLMQYDQC | 571 | Q86SF2 | |
| QYQCLWDMQAENIYN | 1056 | Q14204 | |
| MNEYYRQRNCNLTQI | 726 | Q16099 | |
| LKYENNVMNIRQFNC | 331 | P16298 | |
| MTYVQDQNEDCLYLN | 136 | Q8N0W4 | |
| MVQTEDQYQLCYRAA | 1881 | P10586 | |
| LNYMYNAALEINNAN | 86 | Q3ZCT8 | |
| LLRYYQMQRQSDCRN | 546 | Q9NXL9 | |
| CQYDYFQIKMQNYNN | 316 | Q5K651 | |
| LHEYNQELRMNYNSQ | 46 | Q9UKZ4 | |
| NSYQLCNNGTLRVMY | 1766 | Q9NT68 | |
| QNLAACQNGMNIYFY | 171 | O75626 | |
| SYQLQAQMNRAVYED | 116 | Q9H1Z4 | |
| TQQLMIEAKANYYQC | 186 | Q86YF9 | |
| KQMNTLQCARYVYQT | 166 | Q9BSK2 | |
| QYFQYRQLNLDMFKN | 96 | Q8IUQ0 | |
| LLAQYFEYRQQNLDM | 71 | Q5SYC1 | |
| TSQQNLYRNVMLDNY | 56 | Q14593 | |
| YCNYNSRDQSRIQMH | 1176 | Q86UP3 | |
| NERYIRTSNMQYQCK | 2256 | Q86UP3 | |
| ECSQYQQMLHTNLVY | 46 | Q15532 | |
| QQYEQCMDLQLFYRD | 461 | Q13813 | |
| YMQCQAQVDQLYRNP | 781 | P11216 | |
| QNLYRNVMLDNYRNL | 26 | Q6ZMV8 | |
| MYLREPQNYQSRCQQ | 186 | A6NK53 | |
| NRETELYQYNILQMN | 946 | Q6PGP7 | |
| LYNDVMLENYCNQAS | 56 | Q9Y6Q3 | |
| LQDCNNYNSQSLMDA | 166 | O95405 | |
| CNMNDFQDNRQLYYE | 3576 | Q5THJ4 | |
| QQYSFINQMCYERAL | 106 | Q8TDW0 | |
| NMNIFQKDINCERYY | 496 | P59046 | |
| VLQQLSYFYTTMCQN | 1551 | Q9NQX4 |